| Keywords: |
adult; clinical article; treatment outcome; nonhuman; note; cancer radiotherapy; combined modality therapy; cd8 antigen; t lymphocyte; t-lymphocytes; prostate specific antigen; apoptosis; immune system; gene expression; models, biological; radiotherapy; carcinoembryonic antigen; granulocyte macrophage colony stimulating factor; animal experiment; animal model; cell line, tumor; tumor antigen; genetic vectors; prostate cancer; prostate-specific antigen; prostatic neoplasms; t lymphocyte receptor; cytokine; dna; cancer vaccine; cancer vaccines; major histocompatibility antigen class 2; vaccination; vaccinia virus; cd4 antigen; virus recombinant; recombinant vaccine; ceramide; major histocompatibility antigen class 1; prostate disease; poxvirus; poxviridae; x-rays; protein bax
|
